Diagnosed with Stage 4 esophageal cancer, which has an expected five-year survival rate of less than six percent, the prognosis handed down from his doctors was terminal.
HASKELL FEATURE: McLemore continues to hear positives in battle with cancer


Diagnosed with Stage 4 esophageal cancer, which has an expected five-year survival rate of less than six percent, the prognosis handed down from his doctors was terminal.